Etanercept for acquired hyperostosis syndrome

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Aug 2023: Trial registered, NCT06011889
  2. 4 Sep 2024: Trial started, NCT06011889

The trials

NCT06011889: Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome

State
Under way
Phase
Phase 2 and Phase 3
People
60 planned
Started
4 Sep 2024
Primary completion
18 Oct 2028
Arms
Etanercept
Results
None posted
  1. 25 Aug 2023: Trial registered
  2. 4 Sep 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.